Jérémy T. Campillo

Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually

Jérémy T. Campillo, Cédric B. Chesnais, Sébastien D. S. Pion et al. · Parasites & Vectors · 2020 · 138 citations · Full text

Veterinary Medicine, Biology, Infectious Diseases +15

A Second Population-Based Cohort Study in Cameroon Confirms the Temporal Relationship Between Onchocerciasis and Epilepsy

Cédric B. Chesnais, C. Bizet, Jérémy T. Campillo et al. · Open Forum Infectious Diseases · 2020 · 72 citations · Full text

Medicine, Pediatrics, Epidemiologic Methods +6

Serious adverse reactions associated with ivermectin: A systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World

Jérémy T. Campillo, Michel Boussinesq, Sébastien Bertout et al. · PLoS neglected tropical diseases · 2021 · 56 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial

Jérémy T. Campillo, Paul Bikita, Marlhand C. Hemilembolo et al. · Clinical Infectious Diseases · 2021 · 39 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Excess Mortality Associated With Loiasis: Confirmation by a New Retrospective Cohort Study Conducted in the Republic of Congo

Marlhand C. Hemilembolo, Ange Clauvel Niama, Jérémy T. Campillo et al. · Open Forum Infectious Diseases · 2023 · 38 citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +15